# Elucidating Unknown Organofluorine in Municipal Wastewater: A Mass Balance Approach including Fluorinated Pharmaceuticals

**Authors:** Pontus Larsson, Anna Kärrman, Leo W.Y. Yeung

PMC · DOI: 10.1021/acs.est.5c13161 · 2026-02-20

## TL;DR

This study identifies and quantifies fluorinated compounds in wastewater, revealing that pharmaceuticals contribute significantly to organofluorine despite their low fluorine content.

## Contribution

A novel multisorbent extraction method was developed to better understand fluorine mass balance in wastewater.

## Key findings

- Pharmaceuticals like sitagliptin and bicalutamide contribute 28–42% of extractable organofluorine.
- Low-fluorinated substances are present at much higher concentrations than highly fluorinated ones.
- Inorganic fluoroanions like hexafluorophosphate account for 7–19% of extractable fluorine.

## Abstract

Previous studies on per- and polyfluoroalkyl substances
(PFAS)
have indicated large amounts of unidentified organofluorine in municipal
wastewater, raising concerns about their environmental impact. Here,
a novel multisorbent solid phase extraction method was applied to
municipal wastewater samples, followed by liquid chromatography–high-resolution
mass spectrometry-based screening and a quantification workflow combining
targeted analysis and combustion ion chromatography for fluorine mass
balance analysis. Twenty-three highly fluorinated compounds (i.e.,
perfluoroalkyl acids and precursors) were identified and, apart from
trifluoroacetic acid, quantified in the low- to sub-ppt range. In
contrast, 30 low-fluorinated substances (i.e., active pharmaceutical
ingredients, pesticides, and transformation products, including some
previously unreported metabolites) were identified and quantified
at concentrations up to 3 orders of magnitude higher. Despite their
lower fluorine content (<30% by mass), these pharmaceuticals accounted
for 28–42% of the extractable (organo)fluorine (EOF), with
sitagliptin, bicalutamide, and celecoxib carboxylic acid being important
drivers of the EOF. The inorganic fluoroanions hexafluorophosphate
and tetrafluoroborate were coextracted and contributed 7–19%
of the EOF. The multisorbent approach also captured polar cationic
pharmaceuticals, substantially influencing the EOF composition. These
findings highlight the complexity of fluorine mass balance in municipal
wastewater and the need for advanced methods to uncover unidentified
organofluorine.

## Linked entities

- **Chemicals:** trifluoroacetic acid (PubChem CID 6422), hexafluorophosphate (PubChem CID 9886), tetrafluoroborate (PubChem CID 26255), sitagliptin (PubChem CID 4369359), bicalutamide (PubChem CID 2375), celecoxib carboxylic acid (PubChem CID 10047220)

## Full-text entities

- **Genes:** PFAS (phosphoribosylformylglycinamidine synthase) [NCBI Gene 5198] {aka FGAMS, FGAR-AT, FGARAT, GATD8, PURL}
- **Diseases:** epilepsy (MESH:D004827), inflammatory (MESH:D007249), prostate cancer (MESH:D011471)
- **Chemicals:** fluconazole (MESH:D015725), fluoxetine (MESH:D005473), enzalutamide (MESH:C540278), Spike (MESH:C010346), sulfonate (MESH:D000476), ammonium acetate (MESH:C018824), ammonium hydroxide (MESH:D064753), fluorine compounds (MESH:D017611), PFHxA (MESH:C479228), PFOS (MESH:C076994), rosuvastatin (MESH:D000068718), fluxapyroxad (MESH:C000591719), PFPrA (MESH:C033093), R-134a (MESH:C063006), diflufenican (MESH:C072847), N-vinylpyrrolidone (MESH:C042670), flecainide (MESH:D005424), BF4 (-), fludioxonil (MESH:C108339), fluoroacetate (MESH:D005463), hexafluoroarsenate (MESH:C521298), AR-C124910XX (MESH:C561701), atorvastatin (MESH:D000069059), fipronil sulfone (MESH:C534368), PFSAs (MESH:C040402), TFA (MESH:D014269), chlorine (MESH:D002713), HF (MESH:D006858), oil (MESH:D009821), Celecoxib (MESH:D000068579), 5-fluorouracil (MESH:D005472), water (MESH:D014867), venlafaxine (MESH:D000069470), Per- and polyfluoroalkyl substances (MESH:D005466), F (MESH:D005461), AlF4 - (MESH:C050992), rufinamide (MESH:C079703), lithium (MESH:D008094), 4-hydroxy atorvastatin (MESH:C518964), fluoride (MESH:D005459), sodium fluoride (MESH:D012969), fluopyram (MESH:C572868), M1 (MESH:C400939), acetic acid (MESH:D019342), tetrafluoroborate (MESH:C098759), polyethylene (MESH:D020959), hydroxyl-radical (MESH:D017665), PFOA (MESH:C023036), Fipronil (MESH:C082360), glucuronide (MESH:D020719), Bicalutamide (MESH:C053541), methanol (MESH:D000432), Bis(trifluoromethylsulfonyl)imide (MESH:C538740), CGP 47292 (MESH:C095532), carboxylic acid (MESH:D002264), nitrogen (MESH:D009584), Sitagliptin (MESH:D000068900), TFMS (MESH:C012077), citalopram (MESH:D015283), divinylbenzene (MESH:C004985)
- **Species:** Bos taurus (bovine, species) [taxon 9913], Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12961926/full.md

---
Source: https://tomesphere.com/paper/PMC12961926